• ZEO Scientifix reported revenue of $5.87 million for the eight-month transition period ended June 30, 2026, up 89% year over year.
• Gross profit rose 87% to $4.74 million, while gross margin slipped 0.9 percentage points to 80.8%.
• General and administrative expenses increased 50% to $10.17 million, including about $1.64 million of higher stock-based compensation costs.
• Net loss was $5.07 million, and management said substantial doubt exists about its ability to continue as a going concern.
• Cash climbed to $2.27 million at period-end from $221,000 at the beginning, helped by $2.13 million of financing cash inflows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-011071), on October 13, 2026, and is solely responsible for the information contained therein.